Protein adducts as prospective biomarkers of nevirapine toxicity.
about
Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory scienceBiomonitoring Human Albumin Adducts: The Past, the Present, and the FutureCresyl saligenin phosphate, an organophosphorus toxicant, makes covalent adducts with histidine, lysine, and tyrosine residues of human serum albuminProtein modification by adenine propenalMass Spectrometric Characterization of Human Serum Albumin Adducts Formed with N-Oxidized Metabolites of 2-Amino-1-methylphenylimidazo[4,5-b]pyridine in Human Plasma and HepatocytesComputational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications.Large-scale prediction and testing of drug activity on side-effect targets.N-terminal valine adduct from the anti-HIV drug abacavir in rat haemoglobin as evidence for abacavir metabolism to a reactive aldehyde in vivo.Characterization of protein adducts formed by toxic alkaloids by nano-scale liquid chromatography with mass spectrometry.Synthesis and oxidation of 2-hydroxynevirapine, a metabolite of the HIV reverse transcriptase inhibitor nevirapine.An LC/ESI-SRM/MS method to screen chemically modified hemoglobin: simultaneous analysis for oxidized, nitrated, lipidated, and glycated sites.2'-Deoxythymidine adducts from the anti-HIV drug nevirapine.Differences in nevirapine biotransformation as a factor for its sex-dependent dimorphic profile of adverse drug reactions.Hepatocyte spheroids as a competent in vitro system for drug biotransformation studies: nevirapine as a bioactivation case study.
P2860
Q26778374-64BC23A1-456E-46D9-93A6-E2D04342BA50Q28468289-66577BAB-45CC-464F-85B0-D99B9C41D8F5Q34336979-46E61A32-E355-493C-BAC1-B9A705BE8E13Q34372425-6F6AAA3B-ADA7-48D5-9C59-0A7C0572A0A0Q35624925-D1C96AB4-2F4E-4054-8E2F-F3444A218920Q35646205-AF9F0388-526F-43CA-8AAE-7DFC4E575030Q36059863-1247548C-572D-4320-AC03-248E24C199CAQ36419326-623F3564-80E3-41C9-88A2-8C4BB61A8CFFQ39270092-5054F9AD-ABAA-4E2F-AA5C-063CE186017BQ43484802-AAF1CAEC-A21F-421B-BFF1-96B51EB81C49Q46540977-32CDEE88-D466-43AA-9073-48A4EDE05914Q46731348-E37733B5-D49D-400F-B211-DE5CEB5C0332Q51202282-0E8CF295-6430-4A56-B74F-F23D5A9D1EBFQ51641157-C7C37484-0B04-40AD-A0A7-B1B7D0DFF5B9
P2860
Protein adducts as prospective biomarkers of nevirapine toxicity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Protein adducts as prospective biomarkers of nevirapine toxicity.
@ast
Protein adducts as prospective biomarkers of nevirapine toxicity.
@en
type
label
Protein adducts as prospective biomarkers of nevirapine toxicity.
@ast
Protein adducts as prospective biomarkers of nevirapine toxicity.
@en
prefLabel
Protein adducts as prospective biomarkers of nevirapine toxicity.
@ast
Protein adducts as prospective biomarkers of nevirapine toxicity.
@en
P2860
P50
P356
P1476
Protein adducts as prospective biomarkers of nevirapine toxicity
@en
P2093
Ana L A Godinho
Inês L Martins
P2860
P304
P356
10.1021/TX100186T
P50
P577
2010-09-01T00:00:00Z